Blog

The race to develop and commercialize GLP-1-based therapies for obesity and diabetes has created unprecedented momentum in clinical research. Dozens of sponsors and CROs are simultaneously conducting trials—often in overlapping geographic regions—with many vying for access to the same pool of patients. While this represents exciting progress in metabolic disease treatment, it also presents a

https://healthtechcurated.com/regulatory-and-compliance/how-does-vct-protect-clinical-trials-from-duplicate-subjects/ In the complex realm of clinical trials, preventing the enrollment of duplicate and professional research subjects is critical for maintaining data integrity and ensuring participant safety. As trials expand with overlapping indications and global participation, the risk of unethical subject enrollment increases. These duplicate reseaerch subjects, who join multiple studies without observing necessary washout

Detecting and preventing protocol violations before they ever happen. In today’s complex clinical trial landscape, one issue continues to fly under the radar—duplicate research subjects and professional research subjects. These individuals enroll in multiple trials simultaneously or too close together, often crossing therapeutic areas, sponsors, and trial phases. Left unchecked, these subjects introduce significant risk

The Verified Clinical Trials (VCT) team is excited to attend the 2025 ASCP Annual Meeting, currently taking place in Tucson, Arizona. As the premier event hosted by the American Society of Clinical Psychopharmacology, ASCP brings together global leaders advancing psychiatry and CNS (central nervous system) drug development—and VCT is proud to support that mission. Verified

In the world of clinical research, ensuring participant safety and preserving data integrity are not just goals—they are regulatory and scientific necessities. Yet, a significant blind spot persists in the industry: duplicate subjects in clinical trials and professional research subjects continue to slip through the cracks, threatening the quality of clinical trials globally. Verified Clinical

In the high-stakes world of clinical research, every data point matters. However, a growing and often underestimated threat continues to jeopardize clinical trial outcomes: professional patients in clinical trials. Professional patients—also known as duplicate subjects in clinical trials —are individuals who enroll in multiple clinical trials simultaneously or in rapid succession, often hiding their participation